psyche
Hypervigilance
Adverse effectHypervigilance is a psyche-related effect marked by an unusually heightened state of watchfulness and alertness. It is considered a bad effect, so it reflects a condition that is generally undesirable rather than a benefit.
Hypervigilance refers to a heightened state of alertness. This page offers a plain-language overview of the term and its context.
These are research findings, not promises. Most options have little evidence, and results differ from person to person.
What can cause it
How likely each one is to cause it, most likely first.
Transcendental Meditationpracticesimple.meter.userReports
Based on one study.
Open the Transcendental Meditation page
The expert view shows every study, dose protocol and source.
What can cause it
Interventions reported to bring this on1 listedHighest probability
- →PracticesTranscendental MeditationCertaintyLowSourceAnecdotal1 other source
Some practitioners report increased mental arousal or vigilance, especially during early practice phases.
How to read the evidence
Evidence tier — overall strength of the evidence for the whole compound
- StrongWell established — backed by strong, consistent human research.
- ModerateSome genuine support, but mostly from small or lower-quality studies. Promising, not proven.
- PreliminaryEarly-stage evidence — a promising hypothesis, not an established effect yet.
- LimitedVery limited evidence — treat this as a hypothesis, not proof.
- InsufficientNot enough good evidence to draw conclusions yet.
Certainty — how sure we can be that the effect is real
- Very highVery sure — strong, consistent evidence
- HighFairly sure — consistent evidence from good studies
- MediumModerately sure — new studies could change this
- LowNot sure — little or mixed evidence
- Very lowVery unsure — almost no usable evidence
Source — where the data comes from
- Meta-analysisPooled analysis of many trials — the strongest evidence
- RCTRandomized controlled trial — a strong human study design
- ClinicalA human clinical study
- Reference knowledgeFrom general health-science or pharmacology references, not a study of this exact claim
- Animal researchStudied in animals, not humans
- Community reportsAggregated user reports — anecdotal signal, not evidence
- TheoreticalMechanism-based reasoning, not yet tested
Study grade — quality of each underlying study (A best, D weakest)
- AHigh-quality — strong, consistent human trials
- BGood — solid evidence with some limitations
- CModerate — limited, small, or mixed-quality studies
- DWeak — preliminary, indirect, or animal-only
Confidence — how strongly the sources back a finding
A 0–100 score from study quality and agreement
Most supplement evidence is graded C–D. Read it as preliminary signal, not proof.
Full write-up
What is it
Hypervigilance is a psyche-related effect marked by an unusually heightened state of watchfulness and alertness. It is considered a bad effect, so it reflects a condition that is generally undesirable rather than a benefit.
In this library, it is linked to one intervention: Psilocybin. The single-intervention count means the page is focused on that specific connection rather than a broader set of related factors.
How interventions help
The available evidence for Hypervigilance is very limited. For Psilocybin, there is only anecdotal evidence suggesting a possible relationship, with low probability and just 1 article reported. That means the current information is too sparse to support a clear conclusion about whether it helps, does not help, or has an inconsistent effect.
Because the evidence is anecdotal, this should be read as a preliminary signal rather than a reliable finding. In practice, that means any discussion of Psilocybin and Hypervigilance should be cautious and framed as uncertain. More data would be needed before drawing meaningful conclusions about how this intervention may affect the condition.
Choosing guidance
There is very limited grounding for how to approach hypervigilance with Psilocybin. The only available evidence here is anecdotal, and the relationship is described as low probability, so it should not be treated as a well-established or reliable option for this effect.
For a person comparing options, this means Psilocybin appears in the data as a reported cause of hypervigilance rather than a confirmed or common contributor. Because the evidence is so limited, the main takeaway is that any conclusion about its role would be uncertain. In practical terms, the available information is not enough to support strong expectations either way.